An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder.

MLA

Mariani, John J., et al. “An Open-Label Pilot Study of Pregabalin Pharmacotherapy for Alcohol Use Disorder.” American Journal of Drug & Alcohol Abuse, vol. 47, no. 4, July 2021, pp. 467–75. EBSCOhost, https://doi.org/10.1080/00952990.2021.1901105.

APA

Mariani, J. J., Pavlicova, M., Choi, C. J., Brooks, D. J., Mahony, A. L., Kosoff, Z., Naqvi, N., Brezing, C., Luo, S. X., & Levin, F. R. (2021). An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder. American Journal of Drug & Alcohol Abuse, 47(4), 467–475. https://doi.org/10.1080/00952990.2021.1901105

Chicago

Mariani, John J., Martina Pavlicova, C. Jean Choi, Daniel J. Brooks, Amy L. Mahony, Zora Kosoff, Nasir Naqvi, Christina Brezing, Sean X. Luo, and Frances R. Levin. 2021. “An Open-Label Pilot Study of Pregabalin Pharmacotherapy for Alcohol Use Disorder.” American Journal of Drug & Alcohol Abuse 47 (4): 467–75. doi:10.1080/00952990.2021.1901105.